NR4A3免疫组化与FISH在细针穿刺诊断腺泡细胞癌中的评估及与DOG1比较
该研究在34例细胞学细胞块(含11例腺泡细胞癌)中评估NR4A3免疫组化、NR4A3断裂分离FISH及DOG1免疫组化鉴别腺泡细胞癌的性能。NR4A3免疫组化灵敏度81.8%、特异度100%,优于DOG1免疫组化(72.7%、92%)和NR4A3 FISH(36.4%、100%),且正常腺泡组织均无NR4A3阳性。
要点
- NR4A3免疫组化对腺泡细胞癌高度特异(100%),灵敏度优于DOG1免疫组化。
- NR4A3免疫组化可解决腺泡细胞癌与正常腺泡组织鉴别的难题。
- NR4A3 FISH灵敏度低(36.4%),部分病例因细胞量低无法分析。
核心结论
- NR4A3免疫组化对腺泡细胞癌诊断高度特异,且比DOG1免疫组化和NR4A3 FISH更敏感。
- 联合DOG1免疫组化并未提高NR4A3免疫组化的性能。
- NR4A3阳性有助于区分腺泡细胞癌与正常腺泡组织。
研究设计与样本
- 回顾性研究,纳入34例有病变细胞的细胞学细胞块,其中腺泡细胞癌11例(2例来自同一患者且伴高级别转化)。
- 同时包括分泌性癌2例、涎腺导管癌7例、黏液表皮样癌4例、嗜酸细胞瘤3例、肾细胞癌3例及非肿瘤性涎腺组织6例。
- 所有病例均尝试行NR4A3免疫组化、DOG1免疫组化和NR4A3断裂分离FISH检测。
主要发现
- NR4A3免疫组化对腺泡细胞癌的灵敏度为81.8%,特异度为100%。
- NR4A3 FISH灵敏度为36.4%,特异度为100%,但有4例(3例黏液表皮样癌和1例涎腺组织)因细胞量低无法分析。
- DOG1免疫组化灵敏度为72.7%,特异度为92%。
- 正常腺泡组织标本均无NR4A3免疫组化或FISH阳性。
关键数值与推荐
- NR4A3免疫组化诊断腺泡细胞癌:灵敏度81.8%,特异度100%。
- NR4A3 FISH诊断腺泡细胞癌:灵敏度36.4%,特异度100%(4例无法分析)。
- DOG1免疫组化诊断腺泡细胞癌:灵敏度72.7%,特异度92%。
临床怎么用
- 在细胞学细胞块中,NR4A3免疫组化可作为支持腺泡细胞癌诊断的高特异标志物。
- NR4A3免疫组化有助于鉴别腺泡细胞癌与正常腺泡组织,减少误诊。
- NR4A3 FISH因灵敏度较低且受细胞量限制,不作为首选辅助检测。
局限性
- NR4A3 FISH在4例因细胞量低无法分析,可能影响其性能评估。
- 研究样本量较小(共34例,腺泡细胞癌11例)。
- 为单中心回顾性研究,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acinic cell carcinoma (AcCC) is diagnostically challenging on fine-needle aspiration because it can mimic several other neoplasms or even normal acinar tissue. Immunopositivity for DOG1, especially circumferential membranous staining, can support the diagnosis of AcCC but is not entirely specific, and it is prone to technical and interpretive challenges on small specimens. NR4A3 (nuclear receptor subfamily 4 group A member 3) translocation and nuclear NR4A3 overexpression were recently described in the majority of AcCCs. Here, the authors evaluate the performance of NR4A3 immunohistochemistry (IHC) and NR4A3 break-apart fluorescence in situ hybridization (FISH) on cell block preparations and compare them with DOG1 IHC in distinguishing AcCC from other entities in the differential diagnosis. METHODS: The authors identified 34 cytology cell blocks with lesional cells, including 11 specimens of AcCC (2 of which derived from 1 patient and showed high-grade transformation) as well as 2 secretory carcinomas, 7 salivary duct carcinomas, 4 mucoepidermoid carcinomas, 3 oncocytomas, 3 renal cell carcinomas, and 6 specimens containing nonneoplastic salivary gland tissue. NR4A3 IHC, DOG1 IHC, and NR4A3 FISH were attempted for all cases. RESULTS: NR4A3 IHC had 81.8% sensitivity and 100% specificity for AcCC, whereas NR4A3 FISH had 36.4% sensitivity and 100% specificity, although 4 cases (3 mucoepidermoid carcinomas and 1 salivary gland tissue sample) could not be analyzed because of low cellularity. Notably, no normal acinar tissue specimens showed NR4A3 positivity by IHC or FISH. In addition, DOG1 IHC had 72.7% sensitivity and 92% specificity. CONCLUSIONS: NR4A3 IHC is highly specific for the diagnosis of AcCC and is more sensitive than DOG1 IHC and NR4A3 FISH. In addition, NR4A3 IHC performance is not improved by the inclusion of DOG1 IHC. Finally, NR4A3 positivity resolves the perennial problem of distinguishing AcCC from normal acinar tissue.
引用
- Skaugen JM, Seethala RR, Chiosea SI, et al. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma. Cancer Cytopathol. 2020. PMID: 32809265. doi:10.1002/cncy.22338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。